1Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension[J]. N Engl J Med, 2005,353(20) : 2148-2157.
2Mclaughlin VV,Sitbon O,Badeseh DB,et al. Survival with fist- line bosentan in patients with primary pulmonary hypertension [J]. Eur Respir J,2005,25(2) :244- 249.
3Fukumoto Y, Matoba T, Ito A, et al. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension[J]. Heart,2005,91(3) :391-392.
5McQuillan BM,Picard MH,LeavittM,et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects[J]. Circulation, 2001,104(23):2797-2802.
6Galie N,Torbieki A, Barst R,et al. Guidelines on the diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology [J]. Eur Heart J,2004,25(24) :2243-2278.
10Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension[J]. J Am Coll Cardiol,2004,43 (12 Suppl S) :13S-24S.
5Balke B.A simple field test for the assessment of physical fitness.Rep63-6.Rep Civ Aeromed Res Inst US,1963,53:1-8.
6McGavin CR,Gupta SP,McHardy GJ.Twelve-minute walking test for assessing disability in chronic bronchitis.Br Med J,1976,1:822-823.
7Butland RJ,Pang J,Gross ER,et al.Two-,six-,and 12-minute walking tests in respiratory disease.Br Med J (Clin Res Ed),1982,284:1607-1608.
8Solway S,Brooks D,Lacasse Y,et al.A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain.Chest,2001,119:256-270.
9Guyatt GH,Townsend M,Keller J,et al.Measuring functional status in chronic lung disease:conclusions from a randomized control trial.Respir Med,1991,85(Suppl B):17-21.
10Niederman MS,Clemente PH,Fein AM,et al.Benefits of a multidisciplinary pulmonary rehabilitation program:improvements are independent of lung function.Chest,1991,99:798-804.
